Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Surgery Partners, Inc.SGRY · Entity 4534 | President, National Group | March 15, 2019 | March 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Surgery Partners, Inc.
Report date March 15, 2019 · Filed March 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,527 |
Ending reported balance
After 2019-03-16 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-03-15 · Grant · Acquired 8,740 · Balance 17,486 F1: Shares issued based on 2018 performance under performance stock unit awards granted to the Reporting Person on March 16, 2018. Shares will vest in two equal annual installments on each of the first two anniversaries of December 31, 2018. Row 2 · 2019-03-15 · Grant · Acquired 13,040 · Balance 30,526 F2: Shares will vest in three equal annual installments of each of the first three anniversaries of March 15, 2019. Row 3 · 2019-03-16 · Tax withholding · Disposed 999 · Balance 29,527 F3: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 16, 2019 of restricted stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.42 · Expires 2029-03-15 | Direct | 148,500 |
Reported balance
After 2019-03-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-15 · Grant · Acquired 148,500 · Balance 148,500 F4: One-third (1/3) of the options will vest in three equal installments on each of December 31, 2020, December 31, 2021, and December 31, 2022, generally contingent upon continued employment through each applicable vesting date (the "time condition"). One-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $25.00. The remaining one-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $35.00. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares issued based on 2018 performance under performance stock unit awards granted to the Reporting Person on March 16, 2018. Shares will vest in two equal annual installments on each of the first two anniversaries of December 31, 2018.
F2: Shares will vest in three equal annual installments of each of the first three anniversaries of March 15, 2019.
F3: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 16, 2019 of restricted stock.
F4: One-third (1/3) of the options will vest in three equal installments on each of December 31, 2020, December 31, 2021, and December 31, 2022, generally contingent upon continued employment through each applicable vesting date (the "time condition"). One-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $25.00. The remaining one-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $35.00.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2019 Filed Mar 19, 2019 19:15 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | Tax withholdingCommon Stock | 999 | $13.42 | $13,406.58 |
DisclosureSEC source: 0001638833-19-000017 · wf-form4_155302291638131.xml · nonDerivative · entry 3 Brinkman Carollee · CIK 0001770946 · President, National Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,527 F3 · shares: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting on March 16, 2019 of restricted stock. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 19:15 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantStock Option (Right to Buy) · Derivative | 148,500 | $0.00 Strike: $13.42 | $0.00 |
DisclosureSEC source: 0001638833-19-000017 · wf-form4_155302291638131.xml · derivative · entry 4 Brinkman Carollee · CIK 0001770946 · President, National Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,500 Underlying: Common Stock · 148,500 shares Expires 2029-03-15 F4 · derivative.exercise_date: One-third (1/3) of the options will vest in three equal installments on each of December 31, 2020, December 31, 2021, and December 31, 2022, generally contingent upon continued employment through each applicable vesting date (the "time condition"). One-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $25.00. The remaining one-third (1/3) of the options will vest based on satisfaction of the time condition and the achievement of a closing price per share of the Issuer's Common Stock of $35.00. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 19:15 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 13,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-19-000017 · wf-form4_155302291638131.xml · nonDerivative · entry 2 Brinkman Carollee · CIK 0001770946 · President, National Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,526 F2 · shares: Shares will vest in three equal annual installments of each of the first three anniversaries of March 15, 2019. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 19:15 UTC | Surgery Partners, Inc. SGRY · Entity 4534 | GrantCommon Stock | 8,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001638833-19-000017 · wf-form4_155302291638131.xml · nonDerivative · entry 1 Brinkman Carollee · CIK 0001770946 · President, National Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,486 F1 · shares: Shares issued based on 2018 performance under performance stock unit awards granted to the Reporting Person on March 16, 2018. Shares will vest in two equal annual installments on each of the first two anniversaries of December 31, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.